Clinical efficacy, safety and tolerability of BIO-C® (micronized Silymarin) as a galactagogue www.actabiomedica.it Results:Women orally treated for 63 days with Silymarin showed a clear galactagogue role for the product with an increase of 85.94% of the daily milk production (placebo: +32.09%). No drop out, nor unwanted effects were reported in both groups. Compliance and tolerability […]
So useful! Protocols – The Academy of Breastfeeding Medicine (ABM) www.bfmed.org These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.